In October, Dr Annabel Sowemimo joined us on the Wellcome Genome Campus to speak about her work exploring the ways that racism and colonial thinking are embedded within medicine, science and institutions – and the difficulties of untangling it.
We spoke to Dr Iñigo Martincorena, group leader at the Wellcome Sanger Institute and academic co-founder of Quotient Therapeutics. Quotient is a new company leveraging Sanger Institute research to innovate the way drugs are discovered.
To celebrate Black History Month 2023, we are highlighting some of the incredible Black women on campus. These women, Martha Mulongo, Rachel Ogidan, and Alice Matimba, all have crucial roles in progressing the scientific research that takes place at the Wellcome Genome Campus.
A new, unique scheme to support postdoctoral researchers at the Sanger Institute launched this year. Backed by the Institute’s Equality, Diversity and Inclusion initiative, the scheme aims to build capacity after a period of leave.